Strengthened presence in Europe
08 Julio 2024 - 1:00AM
Strengthened presence in Europe
Press
release Ecully,
July 8, 2024 – 8 a.m.
Spineway continues its sales and
marketing efforts in Europe
The Spineway Group, a specialist in innovative
implants for the treatment of severe spine disorders, announces
that it participated in the 38th edition of GEER, the annual
congress of the Spanish Spine Society, held in Malaga in May.
GEER is the annual meeting of spine surgeons in
Spain, like the SFCR Congress held in Montpellier at the beginning
of June.1 Spineway’s participation in these two international
congresses allowed the company to develop new training partnerships
and to increase its visibility and position in key European
markets. At the SFCR Congress, Spineway recruited a new agent to
strengthen its presence in the Paris-South and North-West regions,
with a view to eventually covering the whole of France.
At GEER, Spineway was present alongside its two
distribution partners, the Palex group and Technospine. Palex is a
major player in import and distribution in Spain (€1 billion in
revenue). Active in all medical and surgical specialties, it is
responsible for expanding sales of Spineway’s arthrodesis ranges in
Spain (in particular the VEOS system). Technospine is responsible
for distributing the Group’s ESP disc prostheses in
Spain.
During the congress, Stéphane Le Roux, Group
CEO, and Fabrice Paccagnella, Global Sales Director, accompanied by
members of the sales and marketing team, presented the VEOS and
ACIFBOX ranges and the Group’s latest innovations to the Spanish
surgical community.
Europe has become the 2nd sales territory since
July 2022 (over 50%), thanks to the acquisitions of Distimp in 2021
and Spine Innovations in July 2022, whose products meet the needs
of spine surgeons. The next major event for Spineway will be the
SILACO Congress in Mexico, from July 24 to 27, which will bring
together spine surgeons from Latin and South America.
Spineway plans to continue its expansion
in Europe and confirms its aim of becoming a major player in less
invasive spine treatments.
Next
event:July 15, 2024 –
H1 2024 revenueJuly 24 to 27, 2024 – SILACO
Congress in Mexico
SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY
SAVINGS PLANS FOR SMES)Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
independent distributors and derives more than 70% of its revenue
from exports.ISIN: FR001400BVK2 –
ALSPW
Contacts:
SPINEWAY GROUPShareholder-services lineAvailable
Tuesday through Thursday+33 (0)806 706 060 |
Eligible PEA / PMEALSPWEuronext Growth |
AELIUMFinance & CommunicationInvestor
relationsSolène Kennisspineway@aelium.fr |
1 Press release of June 10, 2024